NASDAQ · BDSX
Biodesix, Inc.
$24.72+$1.86 (+8.14%)
Biodesix, Inc.’s quoted price sits in the upper half of its reported 52-week range, 22.68% below the high.
Loading market information…
NASDAQ · STRR · USD
Stock price, dividends, earnings
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Star Equity Holdings, Inc.’s quoted price sits in the lower half of its reported 52-week range, 17.63% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Star Equity Holdings, Inc.’s forward annual dividend is $11.00 per share, paid quarterly. The forward yield is 112.13% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Star Equity Holdings, Inc.’s next earnings report is currently expected on Nov 12, 2026, with estimated earnings per share of -$0.13. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Star Equity Holdings, Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Star Equity Holdings, Inc. operates as a diversified multi-industry holding company in Australia, the United States, the United Kingdom, and internationally. It operates through four segments: Building Solutions, Business Services, Energy Services, and Investments. The company manufactures modular buildings, structural wall panels, engineered wood products, and glue-laminated timber for residential, commercial, and industrial markets; and distributes building materials. It also provides customized recruitment and contracting solutions, including recruitment process outsourcing (RPO), project-based RPO, contingent workforce solutions, recruitment consulting, outsourced professional contract staffing, and managed service provider services for mid-to-large multinational companies. In addition, the company engages in the manufacture and supply of specialized drilling tools and downhole equipment used in directional drilling, and other oil and gas well construction applications; and sales and rental of tools in the oil and gas, geothermal, mining, and waterwells sectors. Further, it holds and manages its corporate-owned real estate, as well as investments in various publicly traded and private companies. The company was formerly known as Hudson Global, Inc. and changed its name to Star Equity Holdings, Inc. in September 2025. Star Equity Holdings, Inc. was incorporated in 2003 and is headquartered in Old Greenwich, Connecticut.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 02:24 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| Q1 2025 | May 13, 2025 | -$0.46-866.67% vs estimate | $31.87M-1.5% vs estimate |
|---|
| Q4 2024 | Mar 20, 2025 | -$0.05+16.67% vs estimate | $33.60M-9.6% vs estimate |
|---|
| Q3 2024 | Nov 19, 2024 | -$0.13+23.53% vs estimate | $36.85M-18.78% vs estimate |
|---|
THE ANALYST VIEW
2 ratings in the current snapshot. Strong buy and strong sell are grouped with buy and sell.
Percentages compare targets with the quoted price when currencies match. Targets are analyst estimates, not guaranteed outcomes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$24.72+$1.86 (+8.14%)
Biodesix, Inc.’s quoted price sits in the upper half of its reported 52-week range, 22.68% below the high.
$8.11-$0.31 (-3.68%)
electroCore, Inc.’s quoted price sits in the lower half of its reported 52-week range, 36.14% below the high.
$0.81-$0.03 (-3.13%)
Elutia Inc’s quoted price sits in the lower half of its reported 52-week range, 41.47% below the high.
$19.35+$0.67 (+3.59%)
Precipio, Inc.’s quoted price sits in the lower half of its reported 52-week range, 42.46% below the high.
$2.98+$0.01 (+0.34%)
111, Inc.’s quoted price sits in the lower half of its reported 52-week range, 73.32% below the high.
$3.03-$0.11 (-3.5%)
bioAffinity Technologies, Inc.’s quoted price sits in the lower half of its reported 52-week range, 96.25% below the high.
$0.36-$0.03 (-8.4%)
Dyadic International, Inc.’s quoted price sits in the lower half of its reported 52-week range, 77.44% below the high.
$0.97+$0.11 (+12.96%)
NeuroOne Medical Technologies Corporation’s quoted price sits in the lower half of its reported 52-week range, 84.15% below the high.
